Release Date: 30/10/19 17:45 Summary: Quarterly Activity and Cashflow Reports Price Sensitive: Yes Download Document 773.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%